Indeed, Gal-9 did not negatively impact on the cell viability of MS5 in a single culture, whereas the effective dose of CQ for AML cell killing (50 μM) had a clear negative impact on MS5 cells (Fig. 5B). Here, LGALS9 is linked to acute myeloid leukemia.